Showing results (351-360 of 524) with videos related to

Sort By:
Pageof 53
Journal of Diabetes and Its Complications|April 19, 2017
Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up studySaula Vigili de Kreutzenberg, Anna Solini, Edoardo Vitolo, et al.
Journal of Hypertension|November 1, 2002
Hypertension magnitude and management in the elderly population of SpainJosé R Banegas, Fernando Rodríguez-Artalejo, Luis M Ruilope, et al.
European Heart Journal|June 7, 2024
Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetesMichael Böhm, Alejandro de la Sierra, Felix Mahfoud, et al.
Journal of Hypertension|November 15, 2011
Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppressionCesar Cerezo, Luis M Ruilope, Julian Segura, et al.
Frontiers in Immunology|August 10, 2017
Rapid, Automated, and Specific Immunoassay to Directly Measure Matrix Metalloproteinase-9-Tissue Inhibitor of Metalloproteinase-1 Interactions in Human Plasma Using AlphaLISA Technology: A New Alternative to Classical ELISAHelena Pulido-Olmo, Elena Rodríguez-Sánchez, José Alberto Navarro-García, et al.
Journal of the American Heart Association|December 9, 2017
Prevalence and Clinical Characteristics of Refractory HypertensionPedro Armario, David A Calhoun, Anna Oliveras, et al.
Diabetes, Obesity & Metabolism|September 28, 2021
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trialPeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.
Kidney International|April 23, 2025
Analysis of the prespecified FIDELITY pooled patient dataset examined the efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rateSankar D Navaneethan, Stefan D Anker, Gerasimos Filippatos, et al.
Diabetes, Obesity & Metabolism|March 28, 2018
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetesEmanuela Orsi, Anna Solini, Enzo Bonora, et al.
Diabetologia|July 23, 2018
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre studyGiuseppe Penno, Anna Solini, Emanuela Orsi, et al.
Pageof 53